Gates Grubstake Fund investment decisions are made on a competitive basis by a Scientific Investment Advisory Committee (SIAC). The SIAC comprises a diverse group of subject matter experts and institutional investors with a focus on biotechnology — all dedicated to moving the needle toward commercialization and patient treatment.